Download Complimentary Report Summary

Uncover the decisions, investments and timing behind successful relaunch strategies

Product teams must begin their relaunch planning early to incorporate it into a strong overall lifecycle management strategy. As product teams enter Phase 2 of development for their initial launch, they are often planning their relaunch strategies for years later. Early planning is one of the key factors in making a product relaunch successful.

Cutting Edge Information divided the relaunch strategies outlined in this study into two categories: line extensions and new market entries. Each line extension or new market entry strategy profiled in this study includes a detailed analysis of:

• Implementation costs
• Time to implement
• Strategy outcome in terms of revenue
• Market share protection gained from implementing the tactic

Product relaunch success is a combination of timing, investment and the science behind each drug. A drug manufacturer must first identify whether a compound may be a viable relaunch candidate. Then, the manufacturer must determine the level of investment necessary to bring a relaunch product to market. The next, and perhaps most important, step is for the product team to determine when to relaunch the drug.

Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies includes valuable benchmarks that will help you understand the science, investments and timing behind common relaunch strategies.

Call Adam Bianchi  at 919-403-6583 to get your own copy of "Pharmaceutical Product Relaunch" today.